← All trials
NCT05313035
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 13, 2022
- Primary completion
- Jul 22, 2022
- Completion date
- Mar 31, 2023
- First posted
- Apr 6, 2022
- Last posted
- Aug 9, 2022
- Enrollment
- 360
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- PT Bio FarmaLead sponsor
- University of IndonesiaCollaborator
- University of IndonesiaOverall official - principal investigator
- University of AndalasCollaborator
- Diponegoro UniversityCollaborator
- Universitas HassanudinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.